Modulating the immune response in demyelinating diseases

HUGHES, RAC; Hughes, R
February 1998
Journal of Neurology, Neurosurgery & Psychiatry;Feb1998, Vol. 64 Issue 2, p148
Academic Journal
No abstract available.


Related Articles

  • Modulation of neuronal function by endogenous ion channel blockers in immune-mediated diseases of the nervous system.  // Pflugers Archiv European Journal of Physiology;Apr2000 Supplement, Vol. 439, pR283 

    The article presents an abstract of the study "Modulation of Neuronal Function by Endogenous Ion Channel Blockers in Immune-Mediated Diseases of the Nervous System." Immune-mediated demyelination and axonal degeneration are pathological changes inherent to inflammatory diseases of the central or...

  • Effect of the innate immune response on development of Theiler's murine encephalomyelitis virus-induced demyelinating disease. Olson, Julie // Journal of NeuroVirology;Oct2014, Vol. 20 Issue 5, p427 

    Theiler's murine encephalomyelitis virus (TMEV) infection of susceptible mice leads to the development of demyelinating disease in the central nervous system (CNS) associated with an inflammatory immune response. The demyelinating disease in mice has similarities to multiple sclerosis in humans...

  • Lack of interferon-beta leads to accelerated remyelination in a toxic model of central nervous system demyelination. Trebst, Corinna; Heine, Sandra; Lienenklaus, Stefan; Lindner, Maren; Baumgärtner, Wolfgang; Weiss, Siegfried; Stangel, Martin // Acta Neuropathologica;Dec2007, Vol. 114 Issue 6, p587 

    Interferon-beta (IFN-β) is a pleiotropic cytokine that is known to modulate the immune response in multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system (CNS). Spontaneous remyelination and repair mechanisms in MS are mostly insufficient and contribute...

  • Local Overexpression of Interleukin-11 in the Central Nervous System Limits Demyelination and Enhances Remyelination. Maheshwari, Anurag; Janssens, Kris; Bogie, Jeroen; Van Den Haute, Chris; Struys, Tom; Lambrichts, Ivo; Baekelandt, Veerle; Stinissen, Piet; Hendriks, Jerome J. A.; Slaets, Helena; Hellings, Niels // Mediators of Inflammation;2013, Vol. 2013, p1 

    Demyelination is one of the pathological hallmarks of multiple sclerosis (MS). To date, no therapy is available which directly potentiates endogenous remyelination. Interleukin-11 (IL-11), a member of the gp130 family of cytokines, is upregulated in MS lesions. Systemic IL-11 treatment was shown...

  • Vitamin D and multiple sclerosis. Harandi, Asghar Amini; Harandi, Ali Amini; Pakdaman, Hossein; Sahraian, Mohammad Ali // Iranian Journal of Neurology;2014, Vol. 13 Issue 1, p1 

    Multiple sclerosis (MS) is a chronic demyelinating disease and also is one of the most common disabling neurological disorders in young and middle-aged adults. The main pathogenesis of MS has long been thought to be an immune mediated disorder of the central nervous system. The function of the...

  • Promotion of Remyelination by Sulfasalazine in a Transgenic Zebrafish Model of Demyelination. Suhyun Kim; Yun-Il Lee; Ki-Young Chang; Dong-Won Lee; Young Wan Ha; Ji Eun Na; Im Joo Rhyu; Sang Chul Park; Hae-Chul Park; Sung Chun Cho // Molecules & Cells;2015, Vol. 38 Issue 11, p1013 

    Most of the axons in the vertebrate nervous system are surrounded by a lipid-rich membrane called myelin, which promotes rapid conduction of nerve impulses and protects the axon from being damaged. Multiple sclerosis (MS) is a chronic demyelinating disease of the CNS characterized by...

  • Antioxidants in Multiple Sclerosis: Do They Have a Role in Therapy? Carlson, Noel G.; Rose, John W. // CNS Drugs;2006, Vol. 20 Issue 6, p433 

    Multiple sclerosis (MS) is an immune-mediated disease, with inflammation and neurodegeneration contributing to neuronal demyelination and axonal injury. Current therapies for MS are directed toward modulation of the immune response; however, there is increasing evidence that oxidative stress is...

  • Immunization with structural and non-structural proteins of Theiler's murine encephalomyelitis virus alters demyelinating disease. Tsunoda, Ikuo; Libbey, Jane; Fujinami, Robert // Journal of NeuroVirology;Apr2012, Vol. 18 Issue 2, p127 

    Theiler's murine encephalomyelitis virus (TMEV) causes a demyelinating disease similar to multiple sclerosis in the central nervous system (CNS) of susceptible SJL/J mice. Immune responses to TMEV contribute to viral clearance as well as to demyelination. We constructed recombinant vaccinia...

  • Murine hepatitis virus--A model for virus-induced CNS demyelination. Matthews, A.E.; Weiss, S.R.; Paterson, Y. // Journal of NeuroVirology;Apr2002, Vol. 8 Issue 2, p76 

    Most murine hepatitis virus (MHV) strains, as their name suggests, infect the liver. However, several murine strains are tropic for the central nervous system (CNS) and cause encephalitis with subsequent CNS demyelination. The CNS demyelination shares pathological similarities with human CNS...

  • Control of autoimmune CNS inflammation by astrocytes. Rothhammer, Veit; Quintana, Francisco // Seminars in Immunopathology;Nov2015, Vol. 37 Issue 6, p625 

    Multiple sclerosis is a neurologic disease caused by immune cell infiltration into the central nervous system, resulting in gray and white matter inflammation, progressive demyelination, and neuronal loss. Astrocytes, the most abundant cell population in the central nervous system (CNS), have...


Read the Article


Sign out of this library

Other Topics